Ironwood Pharmaceuticals (IRWD) Change in Cash (2010 - 2026)

Ironwood Pharmaceuticals has reported Change in Cash for 17 years, with the latest figure at $5.0 million in Q1 2026.

• Quarterly Change in Cash fell 74.83% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $112.0 million (up 957.57% YoY) and the FY2025 annual result came in at $126.9 million, up 3629.82% from the prior year.
• Change in Cash slipped to $5.0 million in Q1 2026 per IRWD's latest filing, from $75.0 million in the prior quarter.
• Over five years, Change in Cash peaked at $84.1 million in Q1 2023 and troughed at -$565.5 million in Q2 2023.
• A 5-year average of -$23.6 million and a median of $348000.0 in 2024 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2023 and 2025: Change in Cash tumbled 535.3% in 2023, then surged 21465.8% in 2025.
• Over 5 years, Change in Cash stood at $82.0 million in 2022, then plunged by 123.54% to -$19.3 million in 2023, then soared by 101.8% to $348000.0 in 2024, then soared by 21465.8% to $75.0 million in 2025, then slumped by 93.32% to $5.0 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered $5.0 million, $75.0 million, and $47.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.